|Bid||310.37 x 800|
|Ask||310.74 x 900|
|Day's range||310.57 - 317.28|
|52-week range||203.13 - 323.61|
|Beta (5Y monthly)||0.43|
|PE ratio (TTM)||24.37|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Given all the market uncertainty this year and the downward trend of the major indices, it's no surprise that some investors are hesitant to buy right now. Knowing the right time to pull the trigger on a stock purchase (or a sale) is often one of the hardest parts of being an investor. Three such buy-now opportunities are Vertex Pharmaceuticals (NASDAQ: VRTX), Mattel (NASDAQ: MAT), and Nvidia (NASDAQ: NVDA).
Take Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that has delivered market-beating returns over the past decade. The drugmaker is still at it even amid the market downturn and currently sits near its 52-week high. Vertex has certainly been impressive, but are the company's best days already in the rearview mirror?
GSK's new drug application (NDA) for momelotinib is under standard FDA review, with a decision expected on Jun 16, 2023.